http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1395590-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-147 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-165 |
| filingDate | 1972-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1975-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1395590-A |
| titleOfInvention | Prolactin stimulant |
| abstract | 1395590 Prolactin-inducing materials ABBOTT-LABORATORIES 31 Oct 1972 [1 Nov 1971 19 Sept 1972] 50198/72 Heading A5B The prolactin level in the plasma of female meat-producing mammals is increased by the oral or parenteral administration of the Thyrotropin releasing hormone "TRH" (L- pyroglutamyl-L-histidyl-L-proline amide). It may be administered to milk-producing and meat-producing animals, e.g. parenterally or mixed with their feed, the dosage being 0.001 to 5mg intravenously, 0.1 to 5 mg intramuscularly or 1 to 25 mg orally. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4562197-A |
| priorityDate | 1971-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.